Page last updated: 2024-09-04

carbapenems and Bacterial Disease

carbapenems has been researched along with Bacterial Disease in 275 studies

Research

Studies (275)

Timeframe	Studies, this research(%)	All Research%
pre-1990	15 (5.45)	18.7374
1990's	59 (21.45)	18.2507
2000's	73 (26.55)	29.6817
2010's	89 (32.36)	24.3611
2020's	39 (14.18)	2.80

Authors

Authors	Studies
Abdeta, A; Assefa, D; Bitew, A; Evans, M; Fentaw, S; Kefyalew, Y; Lejisa, T; Tigabu, E; Tsige, E	1
Aitken, SL; Bonomo, RA; Clancy, CJ; Mathers, AJ; Tamma, PD; van Duin, D	1
Cabebe, AE; Eriguchi, Y; Hawes, C; Ouellette, AJ; Pike, K; Schaal, JB; Selsted, ME; Tran, DQ; Tran, PA; Trinh, K	1
Burnham, CD; Eberly, AR; Heitman, AK; Jean, S; Schuetz, AN; Shannon, S; Wallace, MA	1
Agakidou, E; Antachopoulos, C; Darda, VM; Iosifidis, E; Kirvasilis, F; Papakonstantinou, E; Roilides, E; Sdougka, M; Simitsopoulou, M; Zarras, C	1
Biswas, NR; Katiyar, A; Kaur, P; Kumar, A; Kumar, B; Kumar, M; Kumari, N; Priya, P	1
Baghi, HB; Bazmani, A; Beheshtirouy, S; Farzinazar, A; Memar, MY; Rezaee, MA; Sóki, J; Yekani, M	1
Imai, S; Inoue, N; Nagai, H	1
Erickson, D; Kret, L; Oeschger, T	1
Li, W; Liu, K; Liu, Y; Sun, J; Xu, H	1
Gao, X; Guo, B; Wang, J; Wang, Y; Wang, Z; Wen, J	1
Arora, V; Jindal, A; Maiwall, R; Prakash, V; Sarin, SK	1
Chen, X; Feng, Z; Liao, Q; Lin, H; Lin, J; Zhou, Y; Zhuo, H	1
Achiam, MP; Andersen, JS; Granholm, A; Helleberg, M; Hertz, FB; Jonsson, AB; Munch, MW; Møller, MH; Perner, A; Sjövall, F; Steensen, M	1
Das, S; Mallick, A; Mondal, KC; Roy, A; Sarkar, S	1
Chen, Y; Hu, Q; Liu, YP; Long, WM; Qu, J; Qu, Q; Wang, Q; Wu, XL; Xiao, YW; Xu, TT; Zhuang, HH	1
Karłowicz, K; Kierzkowska, M; Majewska, A; Pituch, H	1
Giannella, M; Rinaldi, M; Viale, P	1
Carratalà, J; Grau, I; Padullés, A; Ronda, M; Satorra, P; Shaw, E; Tubau, F; Vigués, F	1
Abebe, T; Belachew, EB; Beshah, D; Derese, SG; Desalegn, Z; Desta, AF; Gebreselasie, S; Tessema, TS; Woldemichael, GB; Zelelie, TZ	1
Feng, DD; Jiang, RL; Lei, S; Wang, X; Xia, GL; Xu, X; You, XB	1
Dolma, KG; Gautam, D; Goyal, RK; Gupta, M; Khandelwal, B; Klangbud, WK; Mitsuwan, W; Nissapatorn, V; Pereira, MLG; Siyadatpanah, A; Wiart, C; Wilairatana, P	1
Bounes, FV; Conil, JM; Fourcade, O; Georges, B; Grare, M; Grossac, J; Labaste, F; Minville, V; Ruiz, S; Seguin, T	1
Aoki, K; Imai, W; Ishii, Y; Morita, T; Murakami, H; Sasaki, M; Tateda, K; Yamada, K	1
Corcione, S; De Rosa, FG; Gentile, I; Lupia, T; Maraolo, AE; Mornese Pinna, S	1
Abner, S; Benin, AL; Dudeck, MA; Edwards, JR; Kallen, AJ; Karlsson, M; Magill, SS; Pollock, D; See, I; Soe, MM; Walters, MS; Weiner-Lastinger, LM	1
Benvenuti, M; Burns, CJ; Chu, GH; Cusick, SM; Daigle, DM; De Luca, F; Docquier, JD; Hamrick, JC; Jackson, RW; Liu, B; Mangani, S; McGarry, D; Pevear, DC; Pozzi, C; Trout, REL; Weiss, WJ; Xerri, L	1
Akazawa, M; Fukuda, H; Mimura, W	1
Baggs, J; Craig, M; Fiore, A; Hatfield, KM; Jernigan, JA; Kallen, A; McCarthy, N; McDonald, LC; Nelson, RE; Olubajo, B; Paul, P; Reddy, SC; Wolford, H	1
Sfeir, MM	1
Berthomieu, D; De Luca, F; Docquier, JD; Feller, G; Galleni, M; Gavara, L; Gresh, N; Hernandez, JF; Legru, A; Marcoccia, F; Mercuri, PS; Nauton, L; Sannio, F; Sevaille, L; Tanfoni, S; Verdirosa, F	1
Campino, S; Chiyangi, H; Clark, TG; Good, L; Katale, BZ; Matee, MI; Misinzo, G; Mshana, SE; Rweyemamu, MM	1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y	1
Arca-Suárez, J; Beceiro, A; Bou, G; Vázquez-Ucha, JC	1
Cappuccio, A; Mancini, E; Oldenkamp, R; Schultsz, C	1
Bille, E; Cohen, JF; Frange, P; Lortholary, O; Parize, P; Pilmis, B; Poline, J; Postaire, M; Toubiana, J; Zahar, JR	1
Castillo, C; Figueroa, C; García, PC; Guggiana, P; Moya-Flores, F; Munita, JM; Rivas, L; Wozniak, A	1
Aranzamendi, M; Calvo Montes, J; Chaves, F; Fariñas, MC; Fernández-Martínez, M; González-Rico, C; Gozalo-Margüello, M; Gracia-Ahufinger, I; Marco, F; Martínez-Martínez, L; Sánchez-Díaz, AM; Vicente-Rangel, T	1
O'Toole, RF	1
Angulmaduwa, S; De Silva, K; Ekanayake, A; Ip, M; Kalupahana, R; Kuthubdeen, S; Liyanapathirana, V; Munasinghe, T; Subhasinghe, S; Vidanapathirana, G	1
Antachopoulos, C; Iosifidis, E	1
Aurilio, C; Borgia, G; Fiore, M; Gentile, I; Leone, S; Maraolo, AE; Pace, MC; Passavanti, MB; Sansone, P	1
Lutz, P; Nattermann, J	1
Lake, JG; Magill, SS; Milstone, AM; Saiman, L; See, I; Weiner, LM	1
Bu, X; Deng, W; Ding, M; Guo, X; Ju, S; Li, Q; Li, X; Li, Y; Liu, Y; Qi, X; Yu, Z; Yuan, G	1
Alviset, S; Batista, R; Bruneau, A; Canouï, E; Charpentier, J; Gauzit, R; Hays, C; Kernéis, S	1
Bogdan, M; Ördög, K; Perić, L; Sóki, J; Urbán, E; Vuković, D	1
Jett, R; Lopez, J; O'Donnell, JN; Rhodes, NJ; Scheetz, MH	1
Ashhurst-Smith, C; Ferguson, JK; Hughes, C	1
Alcorta, A; Echeverría-Esnal, D; Fondevilla, E; Grau, S; Gudiol, F; Limon, E	1
Armstrong, J; Bennie, M; Cockburn, A; Malcolm, W; Mohana, A; Mullen, AB; Patton, A; Robson, SE; Seaton, RA; Sneddon, J	1
Carling, PC	1
Almagor, J; Carmeli, Y; Fallach, N; Gladstone, BP; Tacconelli, E; Temkin, E	1
Celhay, O; Coast, J; Cooper, BS; Do Thi Thuy, N; Guerin, PJ; Lubell, Y; Oppong, R; Phodha, T; Shrestha, P; Wertheim, H	1
Al-Sarira, A; Al-Sarireh, B; Brown, TH; Griffith, D; Mowbray, NG; Wells, T	1
Ida, T; Senju, N; Sugano, T; Takata, T; Takayama, Y	1
Baba, H; Fujibayashi, A; Hatakeyama, D; Itoh, Y; Murakami, N; Niwa, A; Niwa, T; Ohta, H; Suzuki, A; Suzuki, K; Takeichi, S; Tsuchiya, M; Yamamoto, M	1
Fujita, J; Kirikae, T; Kuwahara-Arai, K; Maeda, S; Mya, S; Nakasone, I; Sekiguchi, JI; Tada, T; Tin, HH; Tome, T; Uechi, K; Yanagisawa, I; Zan, KN	1
Bhardwaj, M; De, UK; Dubey, S; Gupta, VK; Or, VK; Pawde, AM; Saraf, A; Singh, BR; Sinha, DK; Vadhana, P	1
Alam, ASMRU; Hossain, MA; Rahaman, MM; Rakhi, NN; Sultana, M	1
Bobola, V; Forbes, W; Frazier, W; Joyner, ML; Manning, CC	1
Achiam, MP; Andersen, JS; Frimodt-Møller, N; Jonsson, AB; Møller, MH; Perner, A; Petersen, MW; Sjövall, F; Steensen, M	1
Aznarte-Padial, P; Calleja Hernández, MÁ; Expósito-Ruiz, M; Hidalgo-Tenorio, C; Pasquau-Liaño, J; Sadyrbaeva-Dolgova, S	1
Fellman, CL; Rosenbaum, MH; Smith, A; Wayne, AS	1
Farooqi, J; Hasan, R; Irfan, S; Jabeen, K; Mehmood, K; Shafquat, Y; Zafar, A	1
Agarwal, S; Bhattacharya, A; Garg, A; Garg, J; Kumar, S; Upadhyay, GC	1
Pati, J; Pattnaik, SK; Ray, B; Sahu, S; Sinha, S	1
Baldolli, A; de La Blanchardière, A; Isnard, C; Perron, J; Saint-Lorant, G	1
Al Saif, S; Aljohany, SM; Alshaalan, M; AlShehri, A; Balkhy, HH; El-Metwally, A; El-Saed, A; Hijazi, O	1
Falagas, ME; Kapaskelis, A; Karageorgopoulos, DE; Tansarli, GS	1
Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ	2
Gupta, N; Rodrigues, C; Shetty, A; Soman, R	1
Damas, P; Frippiat, F; Lambermont, B; Vercheval, C	1
Bonomo, RA; Ecker, DJ; Farrell, JJ; Sampath, R	1
Guzek, A; Korzeniewski, K; Nitsch-Osuch, A; Prokop, E; Rybicki, Z	1
Allegaert, K; Pacifici, GM	1
Li, S; Nelson, DC; Shen, Y; Turko, IV; Wang, M	1
Chen, H; Li, H; Wang, H; Wang, Q; Wang, Z; Zhang, F; Zhao, C	1
Figueras-Nadal, C; Larrosa Escartín, MN; Martínez Gómez, X; Montesinos-Sanchis, E; Moraga-Llop, FA; Oliveras-Arenas, M; Soler-Palacín, P	1
Fujita, T; Hata, H; Hieda, M; Hori, Y; Kobayashi, J; Murata, Y; Nakajima, S; Nakatani, T; Sata, M; Sato, T; Seguchi, O; Sunami, H; Wada, K; Watanabe, T; Yanase, M	1
Igarashi, Y; Inui, K; Ohara, H; Ryozawa, S; Tazuma, S; Tsuyuguchi, T	1
Djordjevic, G; Kula, B; Robinson, JL	1
Gottschalk, R; Hausemann, A; Heudorf, U; Kempf, VA; Kleinkauf, N	1
Behnke, M; Gastmeier, P; Geffers, C; Maechler, F; Peña Diaz, LA; Schröder, C	1
Ishibashi, T; Kubota, R; Matsuo, Y; Wajima, T	1
Bhattacharjee, A; Choudhury, MD; Chowdhury, A; Paul, P; Talukdar, AD	1
Decosterd, LA; Eggimann, P; Fournier, A; Marchetti, O; Pagani, JL; Pannatier, A; Que, YA; Revelly, JP; Voirol, P	1
Li, Y; Liu, J; Lv, Y; Xue, F; Zhang, J; Zheng, B	1
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S	1
Barajas-Nava, LA; Bonfill Cosp, X; Gianneo, OD; Lipsky, BA; Selva Olid, A; Solà, I	1
Maksimova, OO; Martyniuk, VB; Savon, IL; Shapoval, SD; Sofilkanych, MM; Vasylevska, LA; Yakunych, AM	1
Brook, I	2
Bessède, E; Bonnet, F; Camou, F; Issa, N; Le Quellec, F; Morlat, P; Pedeboscq, S; Vandenhende, M	1
Bedouch, P; Bernard, S; Chapuis, C; Foroni, L; Pavese, P; Stahl, JP; Van Hollebeke, M	1
Damer, KM; Roman, C; Solh, T	1
Hallböök, H; Lidström, AK; Pauksens, K	1
Babu Rajendran, N; Burkert, FR; Carmeli, Y; Gkolia, P; Gladstone, BP; Rodríguez-Baño, J; Sifakis, F; Tacconelli, E; Voss, A	1
Chen, NC; Chen, SD; Chuang, YC; Hsiao, SC; Huang, CR; Lin, CH; Lu, YT; Tsai, WC	1
Alberg, T; Blix, HS; Eriksen, HM; Holen, Ø; Neteland, MI; Smith, I	1
Friedland, I; Jasovich, A; Jiang, J; Kaniga, K; Lucasti, C; Umeh, O	1
Mikamo, H; Tanaka, K; Watanabe, K; Yamagishi, Y	1
Chimura, T; Hirayama, T; Murayama, K; Numazaki, M; Ogawa, H	1
Hedge, DD	1
Keam, SJ	1
Masterton, RG	1
Porath, AD	1
French, GL	1
Kattan, JN; Quinn, JP; Villegas, MV	1
Lancaster, JW; Matthews, SJ	1
Citron, DM; Goldstein, EJ	1
Ambrose, PG; Andes, DR; Bhavnani, SM; Van Wart, SA	1
Livermore, DM	2
Igarashi, Y; Inui, K; Ohara, H; Ohya, T; Tazuma, S; Tsuyuguchi, T	1
Dedhia, HV; McKnight, R	1
Antinori, S; Antonelli, M; Bernabei, R; Carosi, G; Cataldo, MA; Cauda, R; Corti, G; De Angelis, G; Fadda, G; Mantengoli, E; Pan, A; Paradisi, F; Radice, A; Rossolini, GM; Spanu, T; Stolzuoli, L; Tacconelli, E	1
Friedland, I; Ketter, N; Redman, R; Rubinstein, E; Zhanel, GG	1
Hayashi, H; Kijima, K; Koresawa, T; Kurosawa, T; Morita, J; Sato, N; Shibasaki, S; Totsuka, K	1
Baba, S; Furukawa, M; Furuya, N; Suzuki, K; Totsuka, K; Ubukata, K; Yamanaka, N	1
Rice, LB	1
Lenoble, M	1
Guery, BP	1
Galal, AM; Gul, W; Noreddin, AM; Slade, D	1
Danishuddin, M; Khan, AU; Shakil, S	1
Chang, HT; Chen, IS; Chou, MY; Hsueh, PR; Huang, WK; Jean, SS; Ko, WC; Lee, WS; Lin, CF; Liu, CY; Liu, YC; Shyr, JM; Teng, LJ; Wang, JH; Wu, JJ	1
Overturf, GD	1
Lin, R; Nandy, P; Samtani, MN	1
Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N	1
Jaworowska, J; Ojdana, D; Ostas, A; Ratajczak, J; Sacha, P; Tryniszewska, E; Wieczorek, P	1
Dubreuil, L; Jean-Pierre, H; Mahieux, S; Marchandin, H; Miara, A; Muller-Serieys, C; Neut, C; Soussy, CJ	1
Cohen, R; Durrmeyer, X	2
Fujimura, S; Fuse, K; Gomi, K; Kariya, Y; Kikuchi, T; Kurokawa, I; Nakano, Y; Takane, H; Tokue, Y; Watanabe, A	1
Cantón, R; García, A; Gimeno, C; Gobernado, M	1
Fisher, JF; Llarrull, LI; Mobashery, S; Testero, SA	1
Buron, JA; Cerrato, SG; Garau, J; Rello, J; Rodriguez, JA; Rossolini, GM; Zaragoza, R	1
Chahine, EB; Ferrill, MJ; Poulakos, MN	1
García, MI; Martínez, MJ; Sánchez, EG; Sánchez, JE	1
Goff, DA; Parbhoo, RK; Schafer, JJ; Winters, HA	1
McKenna, M	1
Bonomo, RA; Patel, G	1
Amyes, SGB; Findlay, J; Hamouda, A	1
Falcone, M; Orsi, GB; Venditti, M	1
Apostolidis, K; Kristo, I; Meletis, G; Miyakis, S; Petridis, M; Sianou, E; Sofianou, D	1
Ben-Ami, R; Bishara, J; Block, C; Chazan, B; Chowers, M; Dan, M; Giladi, M; Kassis, I; Keller, N; Kontoyiannis, DP; Krieger, M; Olshtain-Pops, K; Oren, I; Potasman, I; Shalit, I; Weber, G; Weinberger, M; Wiener-Well, Y; Zimhony, O	1
Botha, F; Burgmann, H; Donath, O; Illievich, UM; Müller, M; Poeppl, W; Wurm, G; Zeitlinger, M	1
Khan, F; Khan, HM; Khan, IM; Malik, A; Shah, MS; Shahid, M; Shujatullah, F; Shukla, I	1
Ichikawa, M; Kurokawa, M; Nannya, Y; Narukawa, K; Toya, T	1
Hawkey, PM; Livermore, DM	1
Cai, YY; Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Lim, CL; Lingegowda, PB; Ong, RW; Tang, SS; Teo, J	1
Hayashi, Y; Rogers, BA	1
Pietroski, N; Schlossberg, D	1
Giller, RH; Nelson, WK; Quinones, R; Rayback, PA	1
Powell, LL; Wilson, SE	1
Barie, PS; Coppa, G; Cryer, HG; Fry, DE; Lee, PC; Martens, MG; Nichols, RL; O'Leary, JP; Rapp, RP; Sirinek, KR; Smith, DW; Wilson, SE	1
Abe, T; Fukuoka, T; Ito, K; Sato, Y; Sei, M	1
Toney, JH	1
Watanabe, A	1
Araake, M; Hara, T; Watabe, H	1
Burstein, E; Chaim, W	1
Livermore, DM; Scott, GM; Sefton, AM	1
Inoue, M; Kaku, M; Nasu, M; Sagawa, K; Yokoyama, T	1
Aihara, M; Baba, H; Fujita, N; Hashikita, G; Hirakata, Y; Hiramatsu, K; Horii, T; Ichiyama, S; Igari, J; Ishigo, S; Ishii, Y; Itaha, H; Itoh, K; Iwata, M; Kaku, M; Kambe, M; Kanemitsu, K; Kanno, H; Kasai, T; Kinoshita, S; Komori, T; Kubo, S; Kusano, N; Maeda, S; Maesaki, S; Matsuda, J; Mihara, E; Miyamoto, H; Murakami, M; Murase, M; Murata, Y; Nakashima, H; Negayama, K; Obata, R; Oguri, T; Okada, J; Ono, J; Saikawa, T; Satoh, T; Shibuya, Y; Suwabe, A; Takahashi, A; Takemura, H; Taminato, T; Tazawa, Y; Uehara, N; Watanabe, N; Yamaguchi, K; Yamanaka, K; Yasujima, M; Yoshida, H; Yoshimura, H	1
Hammond, ML	1
Biedenbach, DJ; Fritsche, TR; Huynh, HK; Jones, RN; Sader, HS	1
Moland, ES; Thomson, KS	1
Song, A	1
Goldstein, EJ	1
Biedenbach, DJ; Huynh, HK; Jones, RN	1
Matsumoto, T; Muratani, T	1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W	1
Ambrose, PG; Bhavnani, SM; Cirincione, BB; Hammel, JP; Wikler, MA	1
Tellado, JM; Wilson, SE	1
Aoki, S; Fujimura, S; Gomi, K; Kikuchi, T; Satoh, T; Tokue, Y; Watanabe, A	1
Anderson, DL	1
Ha, JR; Kim, HG; Kim, J; Kim, JG; Lee, DG; Lee, JM; Lee, SH; Oh, SW	1
Bronze, MS; Cooper, TW; Gibbs, WJ; Greenfield, RA	1
Dilay, L; Hoban, DJ; Karlowsky, JA; Noreddin, AM; Rubinstein, E; Thomson, K; Wiebe, R; Zhanel, GG	1
Bonomo, RA; Vila, J	1
Katsube, T; Yamano, Y; Yano, Y	1
Jankovic, SM; Radonjic, V	1
Lister, PD	1
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA	1
Miyazaki, H	1
Davies, BE; Kirkpatrick, C; Lennon, S; Liu, M; Luedin, E; Mallalieu, NL; Robson, R	1
Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I	1
Asahi, Y; Miyazaki, S; Yamaguchi, K	1
Wilson, SE	1
Fanta, J; Felbr, O; Lochmann, O; Pelák, Z; Vyhnánek, F	1
Iwai, N; Nakamura, H	1
Hayakawa, F; Itomi, K; Kato, T; Kuno, K; Miyajima, Y; Ogawa, A; Okumura, A; Takahashi, H	1
Ihara, T; Itoh, M; Kamiya, H; Kitamura, K; Nakano, T; Sakurai, M	1
Abe, T; Hagiwara, N; Hata, M; Iitsuka, T; Kobayashi, M; Kubota, K; Kudou, S; Nakayama, T; Negishi, S; Tajima, T	1
Kuwahata, K; Niinou, K; Sato, H; Sigeta, M; Suzuki, H	1
Fujii, R; Meguro, H; Terashima, I	1
Ishihara, T; Nakamura, H; Tezuka, T; Toyonaga, Y	1
Akita, H; Iwata, S; Sato, Y; Sunakawa, K; Yokota, T	1
Aoki, S; Nishimura, T; Sugita, K; Takagi, M	1
Haruta, T; Kobayashi, Y	1
Higashino, H; Kino, M; Kobayashi, Y	1
Furukawa, S; Okada, T	1
Okamoto, T; Sekiguchi, T	1
Hamada, F; Kurashige, T; Nagao, A; Okada, T; Wakiguchi, H; Watanabe, S	1
Handa, S; Imai, S; Kato, H; Motohiro, T; Oda, K; Oki, S; Sakata, Y; Yamada, S; Yamashita, F; Yoshinaga, Y	1
Fukuda, T; Gondou, I; Harada, Y; Hayashi, K; Kido, T; Kobayashi, N; Matsumoto, T; Tsuji, Y; Uchida, T; Uehara, Y	1
Norrby, SR	1
Hanberger, H; Nilsson, LE	1
Abe, T; Fujii, R; Meguro, H; Nakamura, H; Niino, K; Sato, H; Suzuki, H; Tajima, T; Terashima, I; Toyonaga, Y	1
Edwards, JR	1
Cravarezza, P; Romanelli, G	1
Diwok, K; Hamacher, J; Kohl, FV; Lichey, J; Lode, H; Vogel, F; Wendel, H	1
Beuscart, C; Mouton, YJ	1
Baker, LW; Hoogkamp-Korstanjep, JA; Huizinga, WK; Karran, SJ; Pezet, DM; Valleur, P; Warren, BL	1
Geroulanos, SJ	1
Faulkner, KL; Lesky, W; Newell, PA; Norrby, SR	1
Blumer, JL; Hutchison, M; Parker, EM	1
Schuler, D	1
Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S	1
Coulton, S; Hunt, E	1
Adam, D	1
Suppola, JP; Vaara, M; Valtonen, VV; Volin, L	1
Abe, S; Bando, T; Hiraga, Y; Hirano, H; Inoue, H; Ito, T; Kawakami, Y; Kikuchi, K; Koba, H; Kobayashi, H; Matsumoto, H; Mouri, T; Nakashima, M; Ohmichi, M; Ohsaki, Y; Saito, A; Sakamoto, M; Shirato, K; Takahashi, M; Takeuchi, K; Tanifuji, Y; Tanno, Y; Yamaguchi, E; Yoshida, M	1
Katsu, K; Nakamura-Kamijo, M; Ohba, F; Watanabe, N	1
Blumer, JL; Bonafede, ME	1
Chang, DC; Wilson, SE	1
Garau, J; Martínez Lacasa, J	1
Bouza, E; Peláez, T	1
Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H	1
Papich, MG	1
Garau, J	1
Gerckens, LS; Gill, CJ; Jackson, JJ; Kropp, H; Pelak, BA; Rosen, H; Sundelof, JG; Thompson, RK	1
Nishino, T; Oh, T; Otsuki, M; Ou, T; Sakagawa, E	1
Bitha, P; Jacobus, NV; Lin, YI; Mikels, SM; Petersen, PJ; Testa, RT; Weiss, WJ	1
Bradley, JS; Garau, J; Lode, H; Quinn, JP; Rolston, KV; Wilson, SE	1
Biedenbach, DJ; Gales, AC; Jones, RN; Lewis, MT; Mathai, D; Yamaguchi, K	1
Kanno, O; Kawamoto, I; Miyauchi, M; Ohya, S; Shibayama, T	1
Betts, MJ; Edwards, JR	1
Hashizume, T; Morishima, H; Nagano, R; Shibata, K	1
Asbel, LE; Levison, ME	1
Hayasaki, Y; Hua, YX; Izumi, K; Mikamo, H; Sato, Y; Tamaya, T	1
Hsiung, A; Kiffer, C; Mendes, C; Mimica, I; Oplustil, C; Sinto, S; Zoccoli, C	1
Aschbacher, R; De Fina, G; Lang, A; Meyer, R; Paluselli, P; Rizza, F; Zelger, P	1
Bonfiglio, G; Nicoletti, G; Russo, G	1
Beguin, Y; Debouge, MH; Fillet, G; Frère, P; Hermanne, JP	1
Sidorenko, SV	1
Beloborodov, VB	1
Bachinskaia, EN; Beloborodova, NV	1
Lahnborg, G; Nord, CE	2
Hopkins, JA; Lami, JL; Wilson, SE	1
Reed, RL	1
Jacobus, NV; Petersen, PJ; Testa, RT; Weiss, WJ	1
Aldridge, KE; Karam, GH; Sanders, CV	1
Neu, HC	1
Butler, K; Gress, J; Lecciones, J; Lee, J; Marshall, D; Pizzo, PA; Roilides, E; Rubin, M; Walsh, T; Weinberger, M	1
Bauernfeind, A; Jungwirth, R; Schweighart, S	1
Nord, CE; Norrby, SR; Rylander, M	1
Lindmark, A; Nord, CE; Persson, I	1
Edwards, JR; Nairn, K; Williams, S	1
Chezzi, C; Leone, F; Menozzi, MG; Molinari, G; Pirali, F; Ravizzola, G; Sanna, A; Schito, GC	1
Castellani, P; Della Bruna, C; Rossi, R; Younes, G	1
Castellani, P; Della Bruna, C; Meinardi, G	1
Hoban, DJ	1
Chin, NX; Neu, HC	1
Naden, M; Watt, B	1
Chanal, C; Chanal, M; Cluzel, M; Cluzel, R; Sirot, D; Sirot, J	1
Boothman, C; King, A; Phillips, I	1
Clarke, AM; Zemcov, SJ	1
Inderlied, CB; Lancero, MG; Young, LS	1

Reviews

81 review(s) available for carbapenems and Bacterial Disease

Article	Year
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 07-06, Volume: 74, Issue:12 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Stenotrophomonas maltophilia	2022
Carbapenem resistance in Bacteroides fragilis: A review of molecular mechanisms. Anaerobe, 2022, Volume: 76 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests	2022
Piperacillin/tazobactam versus carbapenems in patients with severe bacterial infections: A systematic review with meta-analysis. Acta anaesthesiologica Scandinavica, 2023, Volume: 67, Issue:7 Topics: Adult; Bacteria; Bacterial Infections; Carbapenems; Coinfection; Humans; Piperacillin, Tazobactam Drug Combination; Quality of Life	2023
Phenotypic and genotypic identification of carbapenem resistance in Bacteroides fragilis clinical strains. Medical microbiology and immunology, 2023, Volume: 212, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Bacteroides fragilis; Carbapenems; Humans; Meropenem; Microbial Sensitivity Tests	2023
Antimicrobial Resistance in Organ Transplant Recipients. Infectious disease clinics of North America, 2023, Volume: 37, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Organ Transplantation; Transplant Recipients; Vancomycin-Resistant Enterococci	2023
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship. Current opinion in infectious diseases, 2019, Volume: 32, Issue:6 Topics: Antimicrobial Stewardship; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Management; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Treatment Outcome	2019
Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review. Antimicrobial resistance and infection control, 2020, 08-06, Volume: 9, Issue:1 Topics: Africa, Eastern; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Environmental Microbiology; Genetic Variation; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Risk Factors	2020
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams. International journal of molecular sciences, 2020, Dec-06, Volume: 21, Issue:23 Topics: Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Development; Drug Resistance, Bacterial; Humans	2020
The interface between COVID-19 and bacterial healthcare-associated infections. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:12 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Community-Acquired Infections; COVID-19; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Pandemics	2021
Colistin Use in Neonates and Children With Infections Due to Carbapenem-resistant Bacteria. The Pediatric infectious disease journal, 2017, Volume: 36, Issue:9 Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Clinical Trials as Topic; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Infant; Infant, Newborn	2017
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review. World journal of gastroenterology, 2017, Jul-07, Volume: 23, Issue:25 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals; Humans; Liver Cirrhosis; Methicillin; Methicillin-Resistant Staphylococcus aureus; Peritonitis; Practice Guidelines as Topic; Pseudomonas aeruginosa; Treatment Outcome; Vancomycin-Resistant Enterococci	2017
Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis. International journal of antimicrobial agents, 2018, Volume: 52, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Healthcare-Associated Pneumonia; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Odds Ratio; Pseudomonas aeruginosa; Randomized Controlled Trials as Topic; Risk Factors; Staphylococcus aureus; Survival Analysis; Treatment Outcome	2018
Wastewater drains: epidemiology and interventions in 23 carbapenem-resistant organism outbreaks. Infection control and hospital epidemiology, 2018, Volume: 39, Issue:8 Topics: Bacterial Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drainage, Sanitary; Drug Resistance, Bacterial; Equipment Contamination; Hospitals; Humans; Infection Control; Wastewater; Water Microbiology	2018
Piperacillin/tazobactam vs carbapenems for patients with bacterial infection: Protocol for a systematic review. Acta anaesthesiologica Scandinavica, 2019, Volume: 63, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Piperacillin, Tazobactam Drug Combination	2019
Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospital Costs; Humans; Methicillin-Resistant Staphylococcus aureus	2013
Clinical pharmacology of carbapenems in neonates. Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Humans; Infant, Newborn	2014
A systematic review: can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Oct-15, Volume: 59, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Male; Middle Aged; Penicillins; Young Adult	2014
Systemic antibiotics for treating diabetic foot infections. The Cochrane database of systematic reviews, 2015, Sep-04, Issue:9 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Diabetic Foot; Fluoroquinolones; Humans; Penicillins; Randomized Controlled Trials as Topic	2015
[STRATEGY OF ANTIBACTERIAL THERAPY OF SEPSIS. PART I]. Klinichna khirurhiia, 2015, Issue:6 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Typing Techniques; Blood Specimen Collection; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Sepsis	2015
Spectrum and treatment of anaerobic infections. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:1 Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cefoxitin; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Humans; Metronidazole; Minocycline; Penicillins; Tigecycline	2016
Doripenem: a review of its use in the treatment of bacterial infections. Drugs, 2008, Volume: 68, Issue:14 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Humans; Kidney Diseases; Tissue Distribution	2008
The new treatment paradigm and the role of carbapenems. International journal of antimicrobial agents, 2009, Volume: 33, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Humans	2009
What's new and not so new on the antimicrobial horizon? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 6 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Pyrimidines; Research	2008
New developments in carbapenems. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:12 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Microbial; Humans	2008
Doripenem monohydrate, a broad-spectrum carbapenem antibiotic. Clinical therapeutics, 2009, Volume: 31, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests	2009
Activity of a novel carbapenem, doripenem, against anaerobic pathogens. Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Doripenem; Humans; Microbial Sensitivity Tests; Rats	2009
Doripenem: antimicrobial profile and clinical potential. Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4 Topics: Bacteria; Bacterial Infections; Carbapenems; Doripenem; Humans	2009
Doripenem: position in clinical practice. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:5 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections	2009
Overview of seizure-inducing potential of doripenem. Drug safety, 2009, Volume: 32, Issue:9 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Humans; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Seizures; Young Adult	2009
The clinical consequences of antimicrobial resistance. Current opinion in microbiology, 2009, Volume: 12, Issue:5 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fluoroquinolones; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa	2009
[Doripenem: need for a new carbapenem]. Medecine et maladies infectieuses, 2009, Volume: 39, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Carbapenems; Clinical Trials as Topic; Cross Infection; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Humans; Nervous System Diseases; Peritonitis; Pneumonia, Bacterial; Pseudomonas aeruginosa; Urinary Tract Infections	2009
An update on the synthesis and antibacterial effects of carbapenems. Recent patents on anti-infective drug discovery, 2010, Volume: 5, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Drug Discovery; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Structure; Patents as Topic; Structure-Activity Relationship; Treatment Outcome	2010
Doripenem versus bacteria: an emerging battleground. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:5 Topics: Animals; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Humans	2009
Doripenem: an early look at a carbapenem not yet approved for pediatrics. The Pediatric infectious disease journal, 2010, Volume: 29, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Humans; Microbial Sensitivity Tests	2010
The KPC type beta-lactamases: new enzymes that confer resistance to carbapenems in Gram-negative bacilli. Folia histochemica et cytobiologica, 2009, Volume: 47, Issue:4 Topics: Animals; Bacterial Infections; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Molecular Sequence Data	2009
[Pediatric use of carbapenems]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17, Issue:6 Topics: Bacterial Infections; Carbapenems; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Utilization; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Opportunistic Infections; Randomized Controlled Trials as Topic; Treatment Outcome	2010
[Pediatric use of carbapenems]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17 Suppl 4 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Child; Drug Tolerance; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem; Thienamycins	2010
The future of the β-lactams. Current opinion in microbiology, 2010, Volume: 13, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Monobactams	2010
Doripenem: a new carbapenem antibiotic. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Dec-01, Volume: 67, Issue:23 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Formularies, Hospital as Topic; Humans	2010
[Available carbapenems: Properties and differences]. Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28 Suppl 2 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biological Availability; Carbapenems; Cell Wall; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Drug Interactions; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Substrate Specificity; Tissue Distribution	2010
Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Kidney Transplantation; Klebsiella Infections; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pancreas Transplantation; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome	2011
Status report on carbapenemases: challenges and prospects. Expert review of anti-infective therapy, 2011, Volume: 9, Issue:5 Topics: Anti-Bacterial Agents; Australia; Bacterial Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; DNA Transposable Elements; Europe; Forecasting; Gram-Negative Bacteria; Humans; Japan; Middle East; Plasmids; South America; United States	2011
Surveillance and management of multidrug-resistant microorganisms. Expert review of anti-infective therapy, 2011, Volume: 9, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infection Control; Microbial Sensitivity Tests; Public Health; Public Health Surveillance; Risk Factors	2011
Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Carbapenems; Drug Administration Schedule; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome	2013
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection. Surgical infections, 2000, Volume: 1, Issue:1 Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin	2000
[Carbapenem antibiotics]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Active Transport, Cell Nucleus; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cell Membrane Permeability; Drug Design; Drug Resistance, Microbial; Drug Stability; Hexosyltransferases; Humans; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Structure-Activity Relationship	2003
Postpartum infection treatments: a review. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:8 Topics: 4-Quinolones; Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clindamycin; Endometritis; Female; Humans; Mastitis; Metronidazole; Penicillins; Postpartum Period; Thrombophlebitis	2003
Properties and potential of ertapenem. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:3 Topics: Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Drug Resistance, Bacterial; Ertapenem; Half-Life; Humans; Lactams	2003
Doripenem: S 4661. Drugs in R&D, 2003, Volume: 4, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Stability; Humans	2003
Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Ertapenem; Humans; Lactams	2004
Newer carbapenems for urinary tract infections. International journal of antimicrobial agents, 2004, Volume: 24 Suppl 1 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Double-Blind Method; Enterobacteriaceae; Gram-Positive Cocci; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Randomized Controlled Trials as Topic; Urinary Tract Infections; Urine	2004
Appropriate use of the carbapenems. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	2004
Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems. Surgical infections, 2005,Fall, Volume: 6, Issue:3 Topics: Abdominal Cavity; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Humans; Surgical Wound Infection; Treatment Outcome	2005
Doripenem. Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:6 Topics: Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic	2006
Part V. Other beta-lactam antimicrobials. The Journal of the Oklahoma State Medical Association, 2007, Volume: 100, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Humans; Monobactams	2007
Comparative review of the carbapenems. Drugs, 2007, Volume: 67, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Thienamycins	2007
Carbapenems in the USA: focus on doripenem. Expert review of anti-infective therapy, 2007, Volume: 5, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Structure-Activity Relationship; Thienamycins; United States	2007
Treatment of anaerobic infection. Expert review of anti-infective therapy, 2007, Volume: 5, Issue:6 Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Negative-Pressure Wound Therapy; Penicillins; Tigecycline	2007
Carbapenems: monotherapy in intra-abdominal sepsis. Scandinavian journal of infectious diseases. Supplementum, 1995, Volume: 96 Topics: Adult; Bacterial Infections; Carbapenems; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Multicenter Studies as Topic; Peritonitis; Prospective Studies; Randomized Controlled Trials as Topic	1995
Carbapenems. The Medical clinics of North America, 1995, Volume: 79, Issue:4 Topics: Animals; Bacterial Infections; Carbapenems; Humans; Microbial Sensitivity Tests	1995
Meropenem: a microbiological overview. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Animals; Bacterial Infections; Carbapenems; Humans; Meropenem; Thienamycins	1995
Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Bacterial Infections; Carbapenems; Child; Clinical Trials, Phase III as Topic; Humans; Meropenem; Prospective Studies; Randomized Controlled Trials as Topic; Thienamycins; Treatment Outcome	1995
Bacterial resistance to carbapenems. Advances in experimental medicine and biology, 1995, Volume: 390 Topics: Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier Proteins; Enterobacteriaceae; Haemophilus influenzae; Hexosyltransferases; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Zinc	1995
Recent advances in the chemistry and biology of carbapenem antibiotics. Progress in medicinal chemistry, 1996, Volume: 33 Topics: Bacterial Infections; Carbapenems; Drug Resistance, Microbial; Humans	1996
Challenges in the management of serious infections in pediatric patients. The Pediatric infectious disease journal, 1996, Volume: 15, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Carbapenems; Child; Drug Therapy, Combination; Humans	1996
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children. Advances in pediatric infectious diseases, 1996, Volume: 12 Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Molecular Structure; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin	1996
Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections. American journal of surgery, 1997, Volume: 174, Issue:3 Topics: Abdomen; Bacterial Infections; Carbapenems; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Randomized Controlled Trials as Topic; Thienamycins	1997
[The role of carbapenems in the treatment of nosocomial infection]. Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15 Suppl 1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Pneumonia, Bacterial; Skin Diseases, Infectious; Thienamycins	1997
Antibacterial drug therapy. Focus on new drugs. The Veterinary clinics of North America. Small animal practice, 1998, Volume: 28, Issue:2 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Fluoroquinolones; Glycopeptides; Macrolides; Penicillins	1998
Clinical strategies for serious infection: a European perspective. Diagnostic microbiology and infectious disease, 1998, Volume: 31, Issue:2 Topics: Bacterial Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Europe; Humans; Prevalence	1998
Carbapenems in clinical practice: a guide to their use in serious infection. International journal of antimicrobial agents, 1999, Volume: 11, Issue:2 Topics: Bacterial Infections; Carbapenems; Child; Drug Resistance, Microbial; Fever; Humans; Intensive Care Units; Meningitis, Bacterial; Neutropenia; Peritonitis; Pneumonia	1999
Cephalosporins, carbapenems, and monobactams. Infectious disease clinics of North America, 2000, Volume: 14, Issue:2 Topics: Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Humans; Monobactams	2000
Recent developments in carbapenems. Expert opinion on investigational drugs, 2002, Volume: 11, Issue:4 Topics: Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; Carbapenems; Carrier Proteins; Drug Resistance, Bacterial; Hexosyltransferases; Humans; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases	2002
[Broad-spectrum beta-lactamases. Clinical significance and detection methods]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2001, Volume: 46, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cross Infection; Enzyme Inhibitors; Genes, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction	2001
[A choice of antibacterial chemotherapy for nosocomial infections caused by pathogens producing broad-spectrum beta-lactamases]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2001, Volume: 46, Issue:12 Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cross Infection; Humans	2001
[Carbapenems in pediatric practice]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2001, Volume: 46, Issue:12 Topics: Adolescent; Bacterial Infections; Carbapenems; Child; Child, Preschool; Clinical Trials as Topic; Humans; Imipenem; Infant; Infant, Newborn; Meropenem; Postoperative Complications; Thienamycins	2001
Antibiotic choices in surgical intensive care unit patients. The Surgical clinics of North America, 1991, Volume: 71, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Carbapenems; Cephalosporins; Critical Care; Drug Resistance, Microbial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monobactams; Mycoses; Penicillins; Pneumonia; Surgical Wound Infection; Vancomycin	1991
Role of newer antimicrobial agents in the treatment of mixed aerobic and anaerobic infections. Surgery, gynecology & obstetrics, 1991, Volume: 172 Suppl Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bacteroides Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Therapy, Combination; Humans; Penicillins; Streptococcal Infections	1991
Antibacterial therapy: problems and promises, Part I. Hospital practice (Office ed.), 1990, May-15, Volume: 25, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Humans; Monobactams	1990
The febrile neutropenic patient: newer options for empirical therapy. Haematology and blood transfusion, 1990, Volume: 33 Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Neutropenia; Quinolones	1990

Trials

42 trial(s) available for carbapenems and Bacterial Disease

Article	Year
Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult-to-treat spontaneous bacterial peritonitis: A randomized controlled trial. Liver international : official journal of the International Association for the Study of the Liver, 2023, Volume: 43, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Liver Cirrhosis; Meropenem; Peritonitis	2023
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator. Journal of gastroenterology, 2015, Volume: 50, Issue:2 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Carbapenems; Cholangitis; Cholecystitis, Acute; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Young Adult	2015
Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Clinical therapeutics, 2008, Volume: 30, Issue:5 Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins	2008
[Clinical examination of doripenem for infectious diseases in gynecological and associated fields]. The Japanese journal of antibiotics, 2008, Volume: 61, Issue:2 Topics: Bacterial Infections; Carbapenems; Doripenem; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Treatment Outcome	2008
Clinical efficacy of intravenous ciprofloxacin in patients with biliary tract infection: a randomized controlled trial with carbapenem as comparator. Journal of gastroenterology, 2009, Volume: 44, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bile Duct Diseases; Carbapenems; Ciprofloxacin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male	2009
[Pharmacokinetics analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections]. The Japanese journal of antibiotics, 2009, Volume: 62, Issue:2 Topics: Adult; Bacterial Infections; Carbapenems; Dose-Response Relationship, Drug; Female; Humans; Male; Otorhinolaryngologic Diseases	2009
[Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections]. The Japanese journal of antibiotics, 2009, Volume: 62, Issue:2 Topics: Administration, Oral; Adult; Aged; Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Otorhinolaryngologic Diseases; Treatment Outcome; Young Adult	2009
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult	2010
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital. Japanese journal of clinical oncology, 2010, Volume: 40, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult	2010
A comparative analysis of meropenem and doripenem in febrile patients with hematologic malignancies: a single-center retrospective study. Japanese journal of infectious diseases, 2012, Volume: 65, Issue:3 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Female; Fever; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Risk Factors; Thienamycins; Treatment Outcome	2012
Empiric carbapenem monotherapy in pediatric bone marrow transplant recipients. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:9 Topics: Adolescent; Bacterial Infections; Bone Marrow Transplantation; Carbapenems; Child; Child, Preschool; Cilastatin; Drug Costs; Female; Humans; Imipenem; Male; Meropenem; Postoperative Complications; Prospective Studies; Protease Inhibitors; Thienamycins; Vomiting	2002
Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:9 Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Models, Statistical; Monte Carlo Method	2005
Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Adult; Aged; Bacterial Infections; Carbapenems; Creatinine; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Renal Insufficiency	2008
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. Pediatric hematology and oncology, 2008, Volume: 25, Issue:4 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2008
[Laboratory and clinical studies on SY5555 in pediatrics]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:1 Topics: Adolescent; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Half-Life; Humans; Impetigo; Infant; Male; Microbial Sensitivity Tests; Patient Compliance; Respiratory Tract Infections; Urinary Tract Infections	1995
[Clinical studies on SY5555 in the field of pediatrics]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:1 Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Diarrhea; Eosinophilia; Female; Humans; Infant; Male; Respiratory Tract Infections; Scarlet Fever; Urinary Tract Infections	1995
[Studies on SY5555 in the field of pediatrics]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:1 Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Male; Respiratory Tract Infections; Urinary Tract Infections	1995
[Pharmacokinetic, bacteriological, and clinical studies on SY5555 in children]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:1 Topics: Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections	1995
[Clinical studies on SY5555 in pediatric infections]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:1 Topics: Administration, Oral; Adolescent; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Impetigo; Infant; Male; Respiratory Tract Infections; Scarlet Fever; Urinary Tract Infections	1995
[Clinical evaluation of a new oral penem, SY5555, in the pediatric field]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:1 Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Diarrhea; Female; Humans; Infant; Male; Otitis Media; Respiratory Tract Infections; Urinary Tract Infections	1995
[Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:1 Topics: Absorption; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections	1995
[Fundamental and clinical studies of SY5555 in pediatrics]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:1 Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Male; Microbial Sensitivity Tests	1995
[Bacteriological and clinical studies of SY5555 in pediatric field]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:2 Topics: Administration, Oral; Adolescent; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male	1995
[Clinical study of SY5555 dry syrup in the pediatric field]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:2 Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Male	1995
[Clinical evaluation of a new oral penem, SY5555, in infants and children]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:2 Topics: Administration, Oral; Adolescent; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Staphylococcus aureus; Streptococcus pyogenes	1995
[A clinical evaluation of SY5555 in the treatment of pediatric infections]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:2 Topics: Administration, Oral; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male	1995
[Clinical studies on SY5555 in pediatrics]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:2 Topics: Administration, Oral; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Powders; Tablets	1995
[Clinical and laboratory studies on SY5555 in pediatric infectious diseases]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:2 Topics: Administration, Oral; Adolescent; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male	1995
[Pharmacokinetic, bacteriological and clinical studies of SY5555 in the pediatric field]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:2 Topics: Administration, Oral; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Powders	1995
[Pharmacokinetic and clinical studies on SY5555 dry syrup in children]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:2 Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Infant; Male	1995
[Pharmacokinetic and clinical studies of SY5555 in the pediatric field. Pediatric Study Group of SY5555]. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:4 Topics: Absorption; Adolescent; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Dosage Forms; Female; Half-Life; Humans; Infant; Japan; Male; Tablets	1994
Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Bacterial Infections; Carbapenems; Ceftazidime; Cilastatin; Humans; Imipenem; Injections, Intramuscular; Meropenem; Respiratory Tract Infections; Thienamycins; Treatment Outcome; Urinary Tract Infections	1995
Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Bacterial Infections; Bronchitis; Carbapenems; Cilastatin; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Imipenem; Lung Diseases, Obstructive; Meropenem; Prospective Studies; Thienamycins; Treatment Outcome	1995
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections	1995
Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Abdomen; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cefotaxime; Drug Therapy, Combination; Drug Tolerance; Humans; Meropenem; Metronidazole; Middle Aged; Thienamycins; Treatment Outcome	1995
Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Abdomen; Adolescent; Adult; Aged; Bacterial Infections; Carbapenems; Cilastatin; Drug Therapy, Combination; Humans; Imipenem; Injections, Intravenous; Meropenem; Middle Aged; Thienamycins; Treatment Outcome	1995
Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Bacterial Infections; Carbapenems; Child; Clinical Trials, Phase III as Topic; Humans; Meropenem; Prospective Studies; Randomized Controlled Trials as Topic; Thienamycins; Treatment Outcome	1995
Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Humans; Infant; Meropenem; Metronidazole; Thienamycins	1995
[Comparative study on the efficacy of ritipenem acoxil and cefotiam hexetil in chronic lower respiratory tract infections by the double-blind method]. The Japanese journal of antibiotics, 1996, Volume: 49, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Carbapenems; Cefotiam; Cephalosporins; Chronic Disease; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Respiratory Tract Infections	1996
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems. The American surgeon, 1991, Volume: 57, Issue:12 Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins	1991
In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Ciprofloxacin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Thienamycins	1989

Other Studies

154 other study(ies) available for carbapenems and Bacterial Disease

Article	Year
Phenotypic characterization of carbapenem non-susceptible gram-negative bacilli isolated from clinical specimens. PloS one, 2021, Volume: 16, Issue:12 Topics: Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Female; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Male; Prospective Studies	2021
A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections. Scientific reports, 2021, 12-06, Volume: 11, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cytokines; Drug Design; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Gram-Negative Bacterial Infections; Humans; Inflammation; Klebsiella pneumoniae; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Phagocytosis; Sepsis	2021
Development and Validation of a Novel Anaerobic Carbapenem Inactivation Method (Ana-CIM) for the Detection of Carbapenemase Production in Bacteroides fragilis. Journal of clinical microbiology, 2022, 04-20, Volume: 60, Issue:4 Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Bacteroides fragilis; beta-Lactamases; Carbapenems; Ertapenem; Humans; Microbial Sensitivity Tests; Reproducibility of Results	2022
A Longitudinal Study of Spontaneous Gut Decolonization of Carbapenem-resistant Gram-negative Bacteria in Neonatal and Pediatric Patients. The Pediatric infectious disease journal, 2022, 08-01, Volume: 41, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Longitudinal Studies; Retrospective Studies	2022
Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India. Scientific reports, 2022, 05-19, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Escherichia coli; Gram-Negative Bacterial Infections; Humans; India; Klebsiella pneumoniae; Microbial Sensitivity Tests	2022
Economic and clinical burden from carbapenem-resistant bacterial infections and factors contributing: a retrospective study using electronic medical records in Japan. BMC infectious diseases, 2022, Jun-29, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Electronic Health Records; Humans; Japan; Length of Stay; Retrospective Studies	2022
Multiplexed paper-based assay for personalized antimicrobial susceptibility profiling of Carbapenem-resistant Enterobacterales performed in a rechargeable coffee mug. Scientific reports, 2022, 07-14, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Coffee; Humans; Microbial Sensitivity Tests	2022
Investigation and analysis of carbapenem-resistant gram-negative bacterial infection rates across hospitals in Shandong Province in China. Frontiers in public health, 2022, Volume: 10 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans	2022
High prevalence of cfiA positive Bacteroides fragilis isolates collected at a teaching hospital in Hohhot, China. Anaerobe, 2023, Volume: 79 Topics: Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Carbapenems; Child; China; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Prevalence	2023
Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development. Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Retrospective Studies	2023
Customized molecular diagnostics of bacterial bloodstream infections for carbapenem resistance: A convenient and affordable approach. Pathogens and global health, 2023, Volume: 117, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Carbapenems; Humans; Microbial Sensitivity Tests; Pathology, Molecular; Sepsis	2023
Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: A retrospective multicenter observational study. Journal of infection and public health, 2023, Volume: 16, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Ceftazidime; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Microbial Sensitivity Tests; Retrospective Studies	2023
Impact of a prospective audit and feedback antimicrobial stewardship programme on carbapenem consumption: a quasi-experimental study (IPANEMA study). The Journal of antimicrobial chemotherapy, 2023, 07-05, Volume: 78, Issue:7 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Infections; Carbapenems; Feedback; Humans	2023
High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia. PloS one, 2023, Volume: 18, Issue:6 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Cesarean Section; Cross-Sectional Studies; Ethiopia; Female; Gram-Negative Bacteria; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pregnancy; Sepsis; Tertiary Care Centers	2023
Efficacy and nephrotoxicity of polymyxin B in elderly patients with carbapenem resistant bacterial infection. Annals of clinical microbiology and antimicrobials, 2023, Nov-15, Volume: 22, Issue:1 Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Humans; Polymyxin B; Retrospective Studies	2023
Acinetobacter baumannii in suspected bacterial infections: Association between multidrug resistance, virulence genes, & biofilm production. The Indian journal of medical research, 2023, Oct-01, Volume: 158, Issue:4 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Virulence; Virulence Factors	2023
Risk factors for acquisition of carbapenem-resistance during treatment with carbapenem in the intensive care unit: a prospective study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:11 Topics: Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Female; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Risk Factors	2019
Evaluation of inhibitor-combination mCIM for detecting MBL-producing Journal of medical microbiology, 2019, Volume: 68, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Gammaproteobacteria; Humans; Microbial Sensitivity Tests; Penicillins	2019
Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017. Infection control and hospital epidemiology, 2020, Volume: 41, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Catheter-Related Infections; Catheters, Indwelling; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Equipment Contamination; Escherichia coli; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Staphylococcus; Surgical Wound Infection; United States	2020
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections. Journal of medicinal chemistry, 2020, 03-26, Volume: 63, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; Borinic Acids; Carbapenems; Carboxylic Acids; Humans; Mice; Models, Molecular	2020
Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study. Annals of clinical microbiology and antimicrobials, 2020, Feb-17, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefepime; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Young Adult	2020
Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017. The New England journal of medicine, 2020, 04-02, Volume: 382, Issue:14 Topics: Acinetobacter; Adolescent; Adult; Aged; Bacterial Infections; Carbapenems; Cephalosporin Resistance; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Health Surveys; Hospitalization; Humans; Incidence; Infant; Inpatients; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pseudomonas aeruginosa; United States; Vancomycin Resistance; Young Adult	2020
Imipenem-relebactam for Treatment of Carbapenem-resistant Gram-negative Bacteria: Where Do We Stand on In Vitro Susceptibility Testing? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 04-26, Volume: 72, Issue:8 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Carbapenems; Colistin; Double-Blind Method; Gram-Negative Bacteria; Humans; Imipenem	2021
4-( Biomolecules, 2020, 07-23, Volume: 10, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biocatalysis; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Thiones; Triazoles	2020
Filling the gaps in the global prevalence map of clinical antimicrobial resistance. Proceedings of the National Academy of Sciences of the United States of America, 2021, 01-05, Volume: 118, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Escherichia coli; Humans; Klebsiella pneumoniae; Prevalence	2021
Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:5 Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Infections; Carbapenems; Child; Child, Preschool; Cohort Studies; Female; France; Humans; Inappropriate Prescribing; Infant; Male; Middle Aged; Prescriptions	2021
A multispecies outbreak of carbapenem-resistant bacteria harboring the bla BMC microbiology, 2021, 04-09, Volume: 21, Issue:1 Topics: Bacteria; Bacterial Infections; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; DNA Transposable Elements; Gene Transfer, Horizontal; Humans; Pseudomonas aeruginosa	2021
Molecular characterization of multidrug resistant Enterobacterales strains isolated from liver and kidney transplant recipients in Spain. Scientific reports, 2021, 06-04, Volume: 11, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Citrobacter freundii; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Humans; Kidney Transplantation; Klebsiella pneumoniae; Liver Transplantation; Microbial Sensitivity Tests; Pancreas Transplantation; Prevalence; Prospective Studies; Spain; Transplant Recipients	2021
Colonization with selected antibiotic resistant bacteria among a cohort of Sri Lankan university students. BMC infectious diseases, 2021, Jun-15, Volume: 21, Issue:1 Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sri Lanka; Staphylococcal Infections; Students; Universities; Young Adult	2021
Misery acquaints a man with dangerous bedfellows: But how to get rid of them? Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:10 Topics: Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Humans; Liver Failure	2017
Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011-2014. Infection control and hospital epidemiology, 2018, Volume: 39, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Catheter-Related Infections; Catheters, Indwelling; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Equipment Contamination; Escherichia coli; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Pediatrics; Pneumonia, Ventilator-Associated; Staphylococcus; Surgical Wound Infection; United States	2018
Microbiological profile and clinical characteristics of diabetic foot infection in northern China: a retrospective multicentre survey in the Beijing area. Journal of medical microbiology, 2018, Volume: 67, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; China; Diabetic Foot; Enterobacteriaceae; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Surveys and Questionnaires; Tertiary Care Centers	2018
Assessment of appropriate carbapenem prescribing in stewardship programmes. The Journal of hospital infection, 2018, Volume: 100, Issue:3 Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Infections; Carbapenems; Drug Utilization; Female; Health Services Research; Humans; Male; Middle Aged; Prospective Studies	2018
The first characterized carbapenem-resistant Bacteroides fragilis strain from Croatia and the case study for it. Acta microbiologica et immunologica Hungarica, 2018, Aug-01, Volume: 65, Issue:3 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Bacteroides fragilis; Carbapenems; Croatia; Drug Resistance, Bacterial; Humans; Male; Microbial Sensitivity Tests	2018
Gram negative anaerobe susceptibility testing in clinical isolates using Sensititre and Etest methods. Pathology, 2018, Volume: 50, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2018
Widespread increase of empirical carbapenem use in acute care hospitals in Catalonia, Spain. Enfermedades infecciosas y microbiologia clinica (English ed.), 2019, Volume: 37, Issue:1 Topics: Bacterial Infections; Carbapenems; Critical Care; Drug Utilization; Hospitals; Humans; Longitudinal Studies; Retrospective Studies; Spain	2019
Optimizing carbapenem use through a national quality improvement programme. The Journal of antimicrobial chemotherapy, 2018, 08-01, Volume: 73, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Utilization; Female; Health Policy; Health Services Research; Humans; Infant; Infant, Newborn; Male; Middle Aged; Quality Improvement; Scotland; Surveys and Questionnaires; Young Adult	2018
Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. The Lancet. Global health, 2018, Volume: 6, Issue:9 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Global Health; Humans; Klebsiella pneumoniae; Models, Statistical; World Health Organization	2018
Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrobial resistance and infection control, 2018, Volume: 7 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Humans; Macrolides; Quinolones; Thailand; United States	2018
Can infected pancreatic necrosis really be managed conservatively? European journal of gastroenterology & hepatology, 2018, Volume: 30, Issue:11 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Decision-Making; Conservative Treatment; Debridement; Female; Humans; Male; Middle Aged; Pancreatectomy; Pancreatitis, Acute Necrotizing; Patient Selection; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome	2018
Investigations on yearly changes in tebipenem susceptibility of bacterial isolates from pediatric patients -A post-marketing surveillance of tebipenem pivoxil granules for pediatric. The Japanese journal of antibiotics, 2016, Volume: 69, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Child; Child, Preschool; Genotype; Humans; Infant; Microbial Sensitivity Tests; Mutation	2016
Clinical impact of a prospective audit with intervention and feedback without carbapenem restriction in patients receiving carbapenem injection. International journal of clinical practice, 2019, Volume: 73, Issue:1 Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Infections; Carbapenems; Disease-Free Survival; Feedback; Female; Humans; Injections; Male; Medical Audit; Middle Aged; Progression-Free Survival; Prospective Studies	2019
An improved carbapenem inactivation method, CIMTrisII, for carbapenemase production by Gram-negative pathogens. Journal of medical microbiology, 2019, Volume: 68, Issue:2 Topics: Acinetobacter; Anti-Bacterial Agents; Asia, Southeastern; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Humans; Imipenem; Japan; Meropenem; Microbial Sensitivity Tests; Nepal; Pseudomonas; Sensitivity and Specificity; Sequence Analysis, DNA; Time Factors	2019
Antimicrobial Activity of Agarwood Oil Against Multiple-Drug-Resistant (MDR) Microbes of Clinical, Food and Environmental Origin. Current drug discovery technologies, 2020, Volume: 17, Issue:3 Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Birds; Carbapenems; Cattle; Dogs; Drug Resistance, Multiple, Bacterial; Drug Resistance, Multiple, Fungal; Fungi; Horses; Humans; Microbial Sensitivity Tests; Mycoses; Plant Oils; Swine; Thymelaeaceae	2020
Diversity of carbapenemases in clinical isolates: The emergence of bla Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:6 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; Bangladesh; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Microbial Sensitivity Tests; Plasmids	2019
Modeling Ertapenem: the impact of body mass index on distribution of the antibiotic in the body. Mathematical biosciences and engineering : MBE, 2019, 01-15, Volume: 16, Issue:2 Topics: Algorithms; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Body Mass Index; Body Weight; Carbapenems; Computer Simulation; Drug Administration Schedule; Ertapenem; Female; Humans; Male; Models, Theoretical; Obesity; Thinness	2019
Clinical outcomes of carbapenem de-escalation regardless of microbiological results: A propensity score analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 85 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Female; Humans; Male; Middle Aged; Propensity Score; Prospective Studies; Treatment Outcome	2019
Usage patterns of carbapenem antimicrobials in dogs and cats at a veterinary tertiary care hospital. Journal of veterinary internal medicine, 2019, Volume: 33, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Bacterial; Drug Utilization; Female; Hospitals, Animal; Male; Microbial Sensitivity Tests; Retrospective Studies	2019
Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan. Antimicrobial resistance and infection control, 2019, Volume: 8 Topics: Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Length of Stay; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Pakistan; Population Surveillance; Risk Factors; Young Adult	2019
Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria. The Indian journal of medical research, 2019, Volume: 149, Issue:2 Topics: Acinetobacter; Bacterial Infections; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; India; Microbial Sensitivity Tests; Molecular Epidemiology; Pseudomonas aeruginosa	2019
Retrospective analysis of colistin-resistant bacteria in a tertiary care centre in India. The Indian journal of medical research, 2019, Volume: 149, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Urinary Tract Infections	2019
Assessing the relevance of carbapenem prescriptions by an antibiotic stewardship team. Medecine et maladies infectieuses, 2020, Volume: 50, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Infections; beta-Lactamases; Carbapenems; Cross Infection; Drug Prescriptions; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; France; Guideline Adherence; Hospital Departments; Hospitals, University; Humans; Inappropriate Prescribing; Intensive Care Units; Internal Medicine; Male; Middle Aged; Practice Guidelines as Topic; Prospective Studies; Surgery Department, Hospital; Young Adult	2020
Antimicrobial consumption in three pediatric and neonatal intensive care units in Saudi Arabia: 33-month surveillance study. Annals of clinical microbiology and antimicrobials, 2019, Jul-03, Volume: 18, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Epidemiological Monitoring; Female; Humans; Infant; Intensive Care Units, Neonatal; Male; Pediatrics; Prospective Studies; Saudi Arabia; Vancomycin	2019
Reply to Soman et al and Frippiat et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis	2013
Are prolonged/continuous infusions of β-lactams for all? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis	2013
Is extended or continuous infusion of carbapenems the obvious solution to improve clinical outcomes and reduce mortality? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Humans; Penicillanic Acid; Piperacillin	2013
"Salvage microbiology": detection of bacteria directly from clinical specimens following initiation of antimicrobial treatment. PloS one, 2013, Volume: 8, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Decision Making; Drug Resistance, Bacterial; Female; Humans; Male; Microbiological Techniques; Middle Aged; Polymerase Chain Reaction; Prosthesis-Related Infections; Spectrometry, Mass, Electrospray Ionization	2013
In vitro sensitivity of Acinetobacter baumannii and Pseudomonas aeruginosa to carbapenems among intensive care unit patients. Advances in experimental medicine and biology, 2013, Volume: 788 Topics: Acinetobacter baumannii; Bacterial Infections; Carbapenems; Doripenem; Electrophoresis, Gel, Pulsed-Field; Europe; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity; Species Specificity; Thienamycins; United States; United States Food and Drug Administration	2013
Determining carbapenemase activity with 18O labeling and targeted mass spectrometry. Analytical chemistry, 2013, Nov-19, Volume: 85, Issue:22 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Chromatography, Liquid; Drug Resistance, Neoplasm; Meropenem; Oxygen Radioisotopes; Tandem Mass Spectrometry; Thienamycins	2013
In vitro antibacterial activities of two novel oral antibiotics, tebipenem and cefditoren, and other comparators against community-acquired respiratory tract infection-associated bacterial pathogens: a multicentre study in China. International journal of antimicrobial agents, 2014, Volume: 43, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; China; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections	2014
[Carbapenem antibiotics in hospitalised paediatric patients. Adherence to a therapeutic protocol]. Enfermedades infecciosas y microbiologia clinica, 2014, Volume: 32, Issue:10 Topics: Bacterial Infections; Carbapenems; Child, Preschool; Clinical Protocols; Community-Acquired Infections; Female; Guideline Adherence; Hospitalization; Humans; Infant; Male; Retrospective Studies	2014
Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device. Transplantation proceedings, 2014, Volume: 46, Issue:3 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Carbapenems; Doripenem; Female; Heart-Assist Devices; Humans; Male; Retrospective Studies; Teicoplanin; Wounds and Injuries	2014
Burden of carbapenem-resistant organisms in the Frankfurt/Main Metropolitan Area in Germany 2012/2013 - first results and experiences after the introduction of legally mandated reporting. BMC infectious diseases, 2014, Aug-19, Volume: 14 Topics: Adult; Aged; Bacterial Infections; Carbapenems; Communicable Disease Control; Data Collection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Germany; Hospitals; Humans; Male; Middle Aged; Prevalence	2014
Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS). Infection, 2015, Volume: 43, Issue:2 Topics: Bacterial Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Gram-Negative Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Population Surveillance; Prevalence; Staphylococcal Infections; Vancomycin-Resistant Enterococci	2015
Population pharmacokinetics of doripenem in Japanese subjects and Monte-Carlo simulation for patients with renal impairment. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Carbapenems; Computer Simulation; Doripenem; Humans; Japan; Middle Aged; Models, Biological; Models, Statistical; Monte Carlo Method; Renal Insufficiency; Young Adult	2015
Virtual high throughput screening of carbapenem derivatives as new generation carbapenemase and penicillin binding protein inhibitors: a hunt to save drug of last resort. Combinatorial chemistry & high throughput screening, 2015, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Computer-Aided Design; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Molecular Docking Simulation; Molecular Dynamics Simulation; Penicillin-Binding Proteins	2015
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients. Burns : journal of the International Society for Burn Injuries, 2015, Volume: 41, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Surface Area; Burn Units; Burns; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Computer Systems; Critical Illness; Drug Combinations; Drug Monitoring; Female; Humans; Imipenem; Length of Stay; Male; Meropenem; Middle Aged; Retrospective Studies; Thienamycins; Young Adult	2015
Antimicrobial resistance surveillance of doripenem in China. The Journal of antibiotics, 2015, Volume: 68, Issue:8 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; China; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Epidemiological Monitoring; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa	2015
Epidemiology of antimicrobial resistance in an oncology center in eastern India. Infection control and hospital epidemiology, 2015, Volume: 36, Issue:7 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts	2015
Proper use of carbapenems: Role of the infectious disease specialist. Medecine et maladies infectieuses, 2016, Volume: 46, Issue:1 Topics: Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Diagnosis-Related Groups; Drug Prescriptions; Drug Utilization; Education, Medical, Continuing; France; Guideline Adherence; Hospital Bed Capacity, 300 to 499; Hospitals, University; Humans; Inappropriate Prescribing; Infectious Disease Medicine; Interdisciplinary Communication; Medical Audit; Medical Staff, Hospital; Physician's Role; Professional Practice; Referral and Consultation	2016
Compliance with carbapenem guidelines in a university hospital. Medecine et maladies infectieuses, 2016, Volume: 46, Issue:2 Topics: Bacterial Infections; Carbapenems; Community-Acquired Infections; Cross Infection; Female; Guideline Adherence; Hospitals, University; Humans; Male; Middle Aged; Prospective Studies	2016
Who should receive extended infusion beta-lactam therapy? JAAPA : official journal of the American Academy of Physician Assistants, 2016, Volume: 29, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Patient Selection; Penicillins	2016
Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study. Infectious diseases (London, England), 2016, Volume: 48, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Carbapenems; Ciprofloxacin; Cohort Studies; Febrile Neutropenia; Female; Humans; Leukemia; Male; Middle Aged; Mycoses	2016
EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol. BMJ open, 2017, 01-05, Volume: 7, Issue:1 Topics: Acinetobacter baumannii; Bacterial Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Europe; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Research Design; Systematic Reviews as Topic; Vancomycin-Resistant Enterococci	2017
Drug interaction between valproic acid and carbapenems in patients with epileptic seizures. The Kaohsiung journal of medical sciences, 2017, Volume: 33, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticonvulsants; Bacterial Infections; Carbapenems; Contraindications; Drug Antagonism; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Risk Factors; Valproic Acid	2017
Broad-spectrum antibiotics in Norwegian hospitals. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2017, Volume: 137, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization Review; Guideline Adherence; Hospitals; Humans; Norway; Piperacillin; Quinolones; Respiratory Tract Infections	2017
[Clinical investigation on target value of T>MIC in carbapenems]. The Japanese journal of antibiotics, 2008, Volume: 61, Issue:2 Topics: Adult; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Drug Administration Schedule; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Meropenem; Middle Aged; Pelvic Inflammatory Disease; Staphylococcus aureus; Thienamycins	2008
Doripenem: a new carbapenem. South Dakota medicine : the journal of the South Dakota State Medical Association, 2008, Volume: 61, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Humans	2008
Lucasti et al in the May 2008 issue of Clinical Therapeutics. Clinical therapeutics, 2008, Volume: 30, Issue:10 Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Thienamycins	2008
Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients. Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Computer Simulation; Critical Illness; Doripenem; Female; Humans; Mice	2009
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Ciprofloxacin; Cohort Studies; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Hospitals; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pseudomonas aeruginosa; Vancomycin Resistance	2009
[Carbapenem use in severe infections]. Medecine et maladies infectieuses, 2009, Volume: 39, Issue:11 Topics: Bacterial Infections; Carbapenems; Humans; Severity of Illness Index	2009
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: nationwide data from the SMART Programme. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals, Teaching; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prevalence; Taiwan	2010
[Activity of doripenem against anaerobic bacteria]. Pathologie-biologie, 2011, Volume: 59, Issue:2 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Humans; Imipenem; Microbial Sensitivity Tests	2011
Antibacterial activity of carbapenems against clinical isolates of respiratory bacterial pathogens in the northeastern region of Japan in 2007. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Japan; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory Tract Infections	2011
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:3 Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas Infections; Spain; Thienamycins	2010
Nosocomial infections: new therapeutic alternatives. Expert review of anti-infective therapy, 2010, Volume: 8, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic	2010
The enemy within. Scientific American, 2011, Volume: 304, Issue:4 Topics: Bacterial Infections; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Penicillin Resistance; Plasmids	2011
Carbapenems: do they have a future? Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 9 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; Carbapenems; Humans	2011
A cautionary case of microbial solidarity: concurrent isolation of VIM-1-producing Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae from an infected wound. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Enterobacter cloacae; Escherichia coli; Greece; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Wound Infection	2012
European Antibiotic Awareness Day provides platform for campaigns on prudent use of antibiotics for the fourth time. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2011, Nov-17, Volume: 16, Issue:46 Topics: Anniversaries and Special Events; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Europe; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Inappropriate Prescribing; Klebsiella	2011
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida glabrata; Candidemia; Candidiasis; Carbapenems; Clindamycin; Coinfection; Colistin; Drug Resistance, Fungal; Female; Fluconazole; Humans; Israel; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination	2012
Penetration of doripenem in human brain: an observational microdialysis study in patients with acute brain injury. International journal of antimicrobial agents, 2012, Volume: 39, Issue:4 Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Brain; Brain Injuries; Carbapenems; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Microdialysis; Middle Aged; Plasma; Time Factors	2012
NDM-1 in the Indian environment: hitherto the problem is not disquieting. Asian Pacific journal of tropical medicine, 2012, Volume: 5, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Feces; Humans; India; Infant; Water Microbiology; Water Supply	2012
Carbapenem antibiotics for serious infections. BMJ (Clinical research ed.), 2012, May-31, Volume: 344 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Carbapenems; Cephalosporins; Cost-Benefit Analysis; Humans	2012
Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Biomarkers; Calcitonin; Calcitonin Gene-Related Peptide; Carbapenems; Drug Monitoring; Female; Humans; Male; Middle Aged; Neoplasms; Protein Precursors; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Young Adult	2012
An oral carbapenem, but only now intravenous penicillin: the paradox of Japanese antimicrobials. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:12 Topics: Administration, Intravenous; Administration, Oral; Anti-Infective Agents; Bacterial Infections; Carbapenems; Drug Approval; Drug Discovery; Drug Resistance, Bacterial; Humans; Japan; Penicillin G; Practice Guidelines as Topic; Treatment Outcome	2012
Carbapenems. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Humans; Imipenem; Infant; Infant, Newborn; Infant, Premature	2002
Roundtable discussion of antibiotic therapy in surgical infections. Surgical infections, 2000, Volume: 1, Issue:1 Topics: 4-Quinolones; Abdominal Abscess; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drainage; Drug Costs; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Humans; Managed Care Programs; Microbiological Techniques; Minimally Invasive Surgical Procedures; Prescription Fees; Severity of Illness Index; Surgical Wound Infection; Tomography, X-Ray Computed	2000
[Antibacterial activity of panipenem against clinical isolates in 2000 and 2001]. The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6 Topics: Adolescent; Adult; Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Cephalosporins; Child; Dosage Forms; Drug Resistance, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Thienamycins; Time Factors	2002
Metallo-beta-lactamase inhibitors: could they give old antibacterials new life? Current opinion in investigational drugs (London, England : 2000), 2003, Volume: 4, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans	2003
[Antibacterial activity of biapenem against recent clinical isolates]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:2 Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins	2003
[Proper use of carbapenem antibiotics based on the feature in the treatment of infectious diseases (discussion)]]. The Japanese journal of antibiotics, 2004, Volume: 57, Issue:1 Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins; Treatment Failure	2004
[Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2002]. The Japanese journal of antibiotics, 2004, Volume: 57, Issue:1 Topics: Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Humans; Japan; Meropenem; Product Surveillance, Postmarketing; Thienamycins; Time Factors	2004
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Culture Media; Doripenem; Enterobacteriaceae; Enterococcus; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quality Control; Respiratory Tract Infections	2004
CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:2 Topics: Anti-Infective Agents; Bacterial Infections; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Staphylococcus; United States	2004
Retrospective study of clinical outcomes with extended-spectrum beta-lactamases--a different interpretation. Pharmacotherapy, 2004, Volume: 24, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Humans; Retrospective Studies; Time Factors; Treatment Outcome	2004
Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem. Introduction. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams	2004
Activities of doripenem (S-4661) against drug-resistant clinical pathogens. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8 Topics: Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Resistance, Bacterial; Genotype; Gram-Negative Bacteria; Humans; Phenotype	2004
Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004. International journal of antimicrobial agents, 2005, Volume: 26, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Respiratory Tract Infections	2005
CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo. Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cilastatin; Dose-Response Relationship, Drug; Enterococcus faecalis; Escherichia coli; Injections, Intravenous; Meropenem; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Molecular Structure; Protease Inhibitors; Pseudomonas aeruginosa; Pyrrolidines; Staphylococcus aureus; Thienamycins; Vancomycin Resistance	2007
46th Interscience Conference on Antimicrobial Agents and Chemotherapy. Future microbiology, 2007, Volume: 2, Issue:1 Topics: Anti-Infective Agents; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Humans; Macrolides; Oxazolidinones	2007
Pharmacokinetic-pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model. Journal of pharmaceutical sciences, 2008, Volume: 97, Issue:4 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Carbapenems; Cilastatin; Disease Models, Animal; Doripenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Models, Biological; Thienamycins	2008
Utilization rate of carbapenems at intensive care units is not major determinant of gram-negative bacteria resistance to these antibiotics. The Journal of infection, 2007, Volume: 55, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Gram-Negative Bacteria; Humans; Intensive Care Units	2007
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Diabetic Foot; Doripenem; Humans; Microbial Sensitivity Tests	2008
Doripenem (Doribax)--a new parenteral carbapenem. The Medical letter on drugs and therapeutics, 2008, Jan-28, Volume: 50, Issue:1278 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Administration Schedule; Drug Interactions; Humans; Infusions, Intravenous; Pneumonia, Ventilator-Associated; Treatment Outcome; Urinary Tract Infections	2008
[Change in antimicrobial susceptibility of Pseudomonas aeruginosa under restricted use of carbapenems]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2008, Volume: 82, Issue:1 Topics: Bacterial Infections; Carbapenems; Cross Reactions; Drug Resistance, Bacterial; Humans; Pseudomonas aeruginosa	2008
In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Microbial; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests	1995
[New approaches in the use of antibiotics in the treatment of postoperative intra-abdominal infections]. Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti, 1995, Volume: 74, Issue:3 Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Postoperative Complications	1995
Retain intermittent dosing of carbapenems. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:1 Topics: Animals; Bacterial Infections; Carbapenems; Humans; Mice	1994
The pharmacokinetics of meropenem in infants and children: a population analysis. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Age Factors; Analysis of Variance; Bacterial Infections; Body Weight; Carbapenems; Child; Child, Preschool; Creatinine; Humans; Infant; Meropenem; Models, Biological; Thienamycins	1995
[Significant role of carbapenem antibiotics: focused on meropenem (discussion)]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:10 Topics: Bacteria; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Meropenem; Thienamycins	1995
[Antimicrobial activities of meropenem against clinically isolated strains]. The Japanese journal of antibiotics, 1996, Volume: 49, Issue:2 Topics: Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Microbial; Humans; Meropenem; Thienamycins	1996
Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:4 Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	1996
In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Carbapenems; Dipeptidases; Drug Resistance, Multiple; Humans; Kidney; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrrolidines; Swine	1997
[Anti-anaerobic activity of carbapenems]. Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15 Suppl 1 Topics: Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Hydrogen-Ion Concentration; Meropenem; Microbial Sensitivity Tests; Thienamycins	1997
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:12 Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins	1997
In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345). Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:8 Topics: Animals; Bacterial Infections; Carbapenems; Female; Mice; Mice, Inbred DBA; Rats; Rats, Sprague-Dawley	1998
In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:4 Topics: Administration, Oral; Animals; Bacteria; Bacterial Infections; Bacterial Proteins; Carbapenems; Carrier Proteins; Colony Count, Microbial; Drug Resistance, Microbial; Escherichia coli; Hexosyltransferases; Male; Mice; Microbial Sensitivity Tests; Microscopy, Interference; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Prodrugs; Protein Binding	1998
In vivo activities of peptidic prodrugs of novel aminomethyl tetrahydrofuranyl-1 beta-methylcarbapenems. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:3 Topics: Administration, Oral; Animals; Bacterial Infections; Carbapenems; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Injections, Subcutaneous; Mice; Peptides; Prodrugs; Stereoisomerism; Structure-Activity Relationship	1999
Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group. Diagnostic microbiology and infectious disease, 1999, Volume: 34, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Evaluation Studies as Topic; Gram-Negative Bacteria; Humans; Japan; Microbial Sensitivity Tests; Quality Control; Staphylococcus	1999
Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety. The Journal of antibiotics, 1999, Volume: 52, Issue:10 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Carbapenems; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Half-Life; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Stereoisomerism; Structure-Activity Relationship	1999
Carbapenems: the pinnacle of the beta-lactam antibiotics or room for improvement? The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:1 Topics: Acinetobacter; Animals; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2000
Therapeutic efficacy of J-111,225, a novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenem, against experimental murine systemic infections. The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas Infections	2000
In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Rats; Uterine Diseases	2000
Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2000, Volume: 4, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Brazil; Carbapenems; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Intensive Care Units; Lactams; Microbial Sensitivity Tests; Sentinel Surveillance	2000
Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas. The new microbiologica, 2001, Volume: 24, Issue:1 Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Disease Susceptibility; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Humans; Intensive Care Units; Monobactams; Prevalence; Pseudomonas aeruginosa; Staphylococcus aureus	2001
Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone marrow transplantation, 2002, Volume: 29, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Belgium; Carbapenems; Cephalosporins; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Enterococcus; Follow-Up Studies; Gram-Negative Bacteria; Hematopoietic Stem Cell Transplantation; Humans; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcus; Streptococcus; Transplantation, Autologous; Transplantation, Homologous	2002
Efficacy of L-627, a new carbapenem, in the treatment of experimentally induced intra-abdominal infections in rats. Drugs under experimental and clinical research, 1992, Volume: 18, Issue:10 Topics: Abdomen; Animals; Bacterial Infections; Carbapenems; Disease Models, Animal; Gentamicins; Intestines; Male; Metronidazole; Rats; Rats, Sprague-Dawley; Thienamycins	1992
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:1 Topics: Amikacin; Animals; Bacterial Infections; Bacteroides fragilis; Carbapenems; Ceftazidime; Cilastatin; Ciprofloxacin; Dipeptidases; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Klebsiella pneumoniae; Metronidazole; Mice; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins	1991
In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Ceftazidime; Culture Media; Enterobacteriaceae; Germany, West; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa	1989
Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:10 Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Humans; In Vitro Techniques; Microbial Sensitivity Tests	1989
Susceptibility of anaerobic bacteria to meropenem. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Carbapenems; Clostridium; Clostridium perfringens; Fusobacterium; Humans; Meropenem; Microbial Sensitivity Tests; Propionibacterium acnes; Thienamycins	1989
Therapeutic activity of meropenem in experimental infections. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Escherichia coli Infections; Guinea Pigs; Immunosuppression Therapy; Lung Diseases; Male; Meropenem; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Pseudomonas Infections; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections	1989
Efficacy of FCE 22101 compared with imipenem and with gentamicin plus metronidazole in the treatment of experimental intra-abdominal infections in rats. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Gentamicins; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Time Factors	1989
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Female; Half-Life; Lung Diseases; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal	1989
Activity of FCE 22101 and other beta-lactam antibiotics against experimental genital infections in the rat and mouse. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefuroxime; Female; Genital Diseases, Female; Mice; Rats; Surgical Wound Infection; Uterine Diseases; Uterus	1989
In-vitro activity of a new penem FCE 22101. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests	1989
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests	1989
The growth-inhibitory properties of meropenem against anaerobes of clinical importance. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Clindamycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Metronidazole; Microbial Sensitivity Tests; Thienamycins	1989
Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Bacteria; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Positive Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins	1989
Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Bacteria; Bacterial Infections; Carbapenems; Culture Media; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins; United Kingdom	1989
In-vitro activity of meropenem against clinical isolates obtained in Canada. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Bacteria; Bacterial Infections; Canada; Carbapenems; Drug Resistance, Microbial; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins	1989
Bacteriostatic and bactericidal in-vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Amikacin; Bacteria; Bacterial Infections; Carbapenems; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium avium Complex; Thienamycins	1989